Tenax Therapeutics (TENX) Amortizatization of Intangibles (2019 - 2022)
Tenax Therapeutics (TENX) reported Amortizatization of Intangibles of $27857.0 for Q4 2022, up 8.18% on a YoY basis from $25751.0 in Q4 2021, and up 2.03% sequentially from $27303.0 in Q3 2022.
Tenax Therapeutics (TENX) Amortizatization of Intangibles (2019 - 2022) Analysis & Trends
Tenax Therapeutics (TENX) has 4 years of Amortizatization of Intangibles data on file, last reported at $27857.0 in Q4 2022.
- For the quarter ending Q4 2022, Amortizatization of Intangibles rose 8.18% year-over-year to $27857.0; the trailing twelve-month figure through Jun 2023 stood at $55160.0 (down 46.98% YoY), and the FY2022 full-year result was $108189.0, up 3.17% from the prior year.
- Amortizatization of Intangibles advanced to $27857.0 in Q4 2022, from $27303.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $29088.0 in Q1 2021 to a low of $24771.0 in Q2 2021.
- A 4-year average of $26624.2 and a median of $26546.0 in 2019 frame the typical range for Amortizatization of Intangibles.
- Across the five-year window, Amortizatization of Intangibles increased 8.37% in 2021 and retreated 9.73% in 2022, its largest moves.
- Tracing TENX's Amortizatization of Intangibles over 4 years: stood at $26320.0 in 2019, then increased by 8.31% to $28508.0 in 2020, then slipped by 9.67% to $25751.0 in 2021, then advanced by 8.18% to $27857.0 in 2022.
- Business Quant data shows TENX's Amortizatization of Intangibles at $27857.0 in Q4 2022, $27303.0 in Q3 2022, and $26772.0 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 3.22 Mn |
| 10 | Tenax Therapeutics | 655.78 Mn | 655.78 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 27,857.00 |
| Dec 31, 2022 | 27,857.00 |
| Sep 30, 2022 | 27,303.00 |
| Sep 30, 2022 | 27,303.00 |
| Jun 30, 2022 | 26,772.00 |
| Jun 30, 2022 | 26,772.00 |
| Mar 31, 2022 | 26,257.00 |
| Mar 31, 2022 | 26,257.00 |
| Dec 31, 2021 | 25,751.00 |
| Dec 31, 2021 | 25,751.00 |
| Sep 30, 2021 | 25,256.00 |
| Sep 30, 2021 | 25,256.00 |
| Jun 30, 2021 | 24,771.00 |
| Jun 30, 2021 | 24,771.00 |
| Mar 31, 2021 | 29,088.00 |
| Mar 31, 2021 | 29,088.00 |
| Dec 31, 2020 | 28,508.00 |
| Dec 31, 2020 | 28,508.00 |
| Sep 30, 2020 | 27,940.00 |
| Sep 30, 2020 | 27,940.00 |